# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: William Shakespeare (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE005-SYN-TD
- Date: 1616-03-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rowena Achterberg-Sule, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Review after four weeks on propranolol 80 mg, with liver tests. **S**

## History of present illness

Mr. Shakespeare returns four weeks after the propranolol dose was increased to 80 mg each morning. He has had two occupational therapy sessions: he now writes with a weighted, wide-grip pen, rests his forearm on the desk, writes a little larger and slower, and dictates long drafts. He can sign his name steadily if he signs halfway down a page rather than at the very foot. He has had no dizziness, wheeze, cold hands, fatigue, or low mood. He has kept within the agreed limits since the brief intervention ten weeks ago, at about 10 drinks a week with no day above three for the last five, and two cups of coffee. He feels his hand is his own again. **S**

| Element | Detail |
|---|---|
| Medication | Propranolol extended-release 80 mg for four weeks; no side effects |
| Occupational therapy | Two sessions; weighted wide-grip pen, forearm support, dictation |
| Writing | Full pages legible; signature steady |
| Alcohol | Within limits for ten weeks; about 10 drinks a week for the last five |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Mild residual tremor when tired; no new symptoms |
| Cardiovascular | Negative | No dizziness or fainting |
| Respiratory | Negative | No wheeze |
| Psychiatric | Negative | Mood good |

4 systems reviewed. **S**

## Current medications

- Propranolol extended-release 80 mg oral capsule, one capsule by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 62 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 80.8 kg; BMI 26.4 kg/m². All vital signs are synthetic.

GGT: 49 U/L; ALT: 30 U/L; AST: 29 U/L. All results are synthetic.

## Change since baseline

- GGT: 84 U/L (high) at baseline, 49 U/L at this visit **S**
- ALT: 41 U/L at baseline, 30 U/L at this visit **S**
- AST: 44 U/L at baseline, 29 U/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| Cardiovascular | Heart rate 62, regular; blood pressure 120/76 mmHg seated and 118/76 mmHg standing |
| Respiratory | Clear |
| Abdomen | Liver not enlarged |
| Neurological | Mild postural and kinetic tremor of both hands, right more than left; no rest tremor or other signs |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential tremor** (G25.0). Good response to propranolol 80 mg with occupational therapy: TETRAS performance 12 (from 22 at diagnosis), activities of daily living 9 (from 18), writing item 1.5. Pulse 62 and blood pressure 120/76 mmHg without side effects. **S**
   - Continue propranolol extended-release 80 mg each morning.
   - Continue the occupational therapy techniques.
   - Review in three months; sooner if the tremor changes or new signs appear.
2. **Hazardous drinking** (Z72.89). Ten weeks within the agreed limits; GGT 49 U/L (from 84), ALT 30 and AST 29 U/L: the liver tests have normalized. **S**
   - Keep to the limits; repeat AUDIT at the next preventive visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Tremor rating: TETRAS performance and activities of daily living subscales | At each visit while treatment is adjusted | Completed today | Performance 12 (from 22) and activities of daily living 9 (from 18); writing item 1.5 |
| Examination | Archimedes spiral and handwriting sample (the same sentence each time, dated and kept in the chart) | At each visit while treatment is adjusted | Completed today | Right spiral close to the left, with a small tremor axis; handwriting even and legible across a full page |
| Medication safety | Beta-blocker safety: resting pulse, seated and standing blood pressure, wheeze, fatigue, cold hands, low mood, exercise tolerance | At each visit after starting or changing the dose | Completed today | Pulse 62; blood pressure 120/76 mmHg with no postural drop; no wheeze, fatigue, cold hands, or low mood |
| Self-management | Drinking review after the brief intervention (drinks a week, heaviest day, use of alcohol to steady the hand) | At each visit after a brief intervention | Completed today | About 10 drinks a week for the last five weeks, no day above three; within limits for ten weeks |
| Laboratory | GGT and liver tests after reducing alcohol | Eight to twelve weeks after the brief intervention | Completed today | GGT 49 U/L (from 84), ALT 30 U/L, AST 29 U/L |
| Referral | Occupational therapy for writing | When tremor limits writing | Completed today | Two sessions completed; techniques in use |
| Self-management | Advance care planning and goals of care | Once, then when health or wishes change | Up to date | Discussed at the preventive visit; health care agent named |
| Medication safety | Primidone (sedation, unsteadiness, nausea) | Only if used | Not indicated | Not started; propranolol is effective and tolerated |
| Imaging | Brain MRI or dopamine transporter imaging | Only for atypical features (rest tremor, parkinsonism, asymmetry with other signs, sudden onset, ataxia) | Not indicated | No atypical features; the diagnosis is clinical |
| Referral | Deep brain stimulation or focused ultrasound thalamotomy | Only for disabling tremor despite adequate trials of two first-line drugs | Not indicated | Tremor responding to the first drug |

## Goal progress

- Classify the tremor and exclude treatable causes by the second visit. Outcome by 1616-01-26: Essential tremor diagnosed; TSH, glucose, calcium, and kidney tests normal; no parkinsonism. **S**
- Legible handwriting for a full page and a steady signature. In progress; target 1616-04-20. **S**
- No more than 14 standard drinks a week and no more than 4 on any day. In progress; target 1616-04-20. **S**
- Resting pulse above 55 without dizziness, wheeze, or fatigue on propranolol. In progress; target 1616-04-20. **S**

## Guideline basis

- Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011; reaffirmed 2025) (2011), American Academy of Neurology (Neurology)
- Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018), International Parkinson and Movement Disorder Society (Movement Disorders)
- MDS evidence-based review of treatments for essential tremor (2019), International Parkinson and Movement Disorder Society (Movement Disorders)
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Helping Patients Who Drink Too Much: A Clinician's Guide (2005), National Institute on Alcohol Abuse and Alcoholism
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge

## Follow-up

- Tremor review in three months; second zoster dose due in the next two months; he has not yet returned the fecal immunochemical test kit and was reminded today. **S**

